Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India · Delayed Price · Currency is INR 4,571.20
-1.00 (-0.02%)
Jun 12, 2026, 3:29 PM IST
Torrent Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 21,634 | 19,113 | 16,564 | 12,452 | 7,772 |
Depreciation & Amortization | 11,042 | 7,740 | 7,748 | 6,830 | 6,427 |
Other Amortization | 145.1 | 209.3 | 204.6 | 190.3 | 192.8 |
Loss (Gain) From Sale of Assets | -176.6 | -13.4 | -883.6 | -216.2 | 8.2 |
Asset Writedown & Restructuring Costs | 1.7 | - | 129.7 | 45.6 | 2.3 |
Loss (Gain) From Sale of Investments | -316.7 | -167.3 | -179.9 | -195.1 | -101.4 |
Provision & Write-off of Bad Debts | 55.4 | 17.7 | 70.8 | 22.7 | 9 |
Other Operating Activities | 1,262 | 3,762 | 4,826 | 4,734 | 7,239 |
Change in Accounts Receivable | -2,539 | 171.7 | 783.2 | -2,897 | -1,091 |
Change in Inventory | 343.8 | -2,622 | -494.3 | 2,557 | 2,189 |
Change in Accounts Payable | 1,641 | -2,777 | 4,136 | -580.2 | -3,924 |
Change in Other Net Operating Assets | -2,865 | 418.1 | -243.6 | 738.3 | -692.5 |
Operating Cash Flow | 30,227 | 25,851 | 32,661 | 23,681 | 18,030 |
Operating Cash Flow Growth | 16.93% | -20.85% | 37.92% | 31.34% | -10.09% |
Capital Expenditures | -6,774 | -6,119 | -4,328 | -5,739 | -2,026 |
Sale of Property, Plant & Equipment | 409.5 | 177.7 | 1,337 | 1,587 | 67.9 |
Cash Acquisitions | -123,150 | - | - | -20,000 | - |
Investment in Securities | 2,028 | 337.9 | 1,181 | -129.8 | -80.9 |
Other Investing Activities | 361.4 | 202.6 | 131.2 | 129 | 72.4 |
Investing Cash Flow | -127,124 | -5,401 | -1,679 | -24,153 | -1,966 |
Short-Term Debt Issued | 16,041 | - | - | 8,420 | 2,186 |
Long-Term Debt Issued | 109,900 | - | - | 13,950 | - |
Total Debt Issued | 125,941 | - | - | 22,370 | 2,186 |
Short-Term Debt Repaid | - | -3,963 | -1,334 | - | - |
Long-Term Debt Repaid | -7,271 | -5,564 | -12,599 | -9,936 | -10,651 |
Total Debt Repaid | -7,271 | -9,527 | -13,933 | -9,936 | -10,651 |
Net Debt Issued (Repaid) | 118,670 | -9,527 | -13,933 | 12,434 | -8,464 |
Common Dividends Paid | -12,889 | -10,830 | -10,153 | -5,132 | -6,769 |
Other Financing Activities | -4,275 | -2,622 | -3,710 | -3,030 | -2,577 |
Financing Cash Flow | 101,506 | -22,980 | -27,796 | 773.6 | -17,811 |
Foreign Exchange Rate Adjustments | 828.2 | -87.3 | 80.7 | 211.2 | 5.3 |
Miscellaneous Cash Flow Adjustments | - | - | - | 588.3 | - |
Net Cash Flow | 5,437 | -2,617 | 3,266 | 1,101 | -1,742 |
Free Cash Flow | 23,453 | 19,732 | 28,333 | 17,942 | 16,004 |
Free Cash Flow Growth | 18.86% | -30.35% | 57.92% | 12.11% | -4.18% |
Free Cash Flow Margin | 16.78% | 17.14% | 26.41% | 18.65% | 18.81% |
Free Cash Flow Per Share | 69.30 | 58.30 | 83.72 | 53.01 | 47.29 |
Cash Interest Paid | 4,275 | 2,622 | 3,710 | 3,030 | 2,577 |
Cash Income Tax Paid | 8,089 | 6,028 | 4,981 | 3,981 | 4,210 |
Levered Free Cash Flow | 26,012 | 12,787 | 22,213 | 14,783 | 10,209 |
Unlevered Free Cash Flow | 28,417 | 14,358 | 24,417 | 16,860 | 11,790 |
Change in Working Capital | -3,420 | -4,809 | 4,181 | -182 | -3,519 |